<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cureveda Launches “Weight-Gut” — A New-Age, Natural Solution Tackling Bloating, Cravings, and Stubborn Fat Through Gut Health</title>
    <link>https://www.taxtmi.com/news?id=46424</link>
    <description>Cureveda markets Weight Gut as a plant based enzyme and botanical formulation that targets poor digestion to reduce bloating, curb cravings, and support fat metabolism. The product combines a patented multi enzyme complex with botanicals purported to improve digestion, nutrient assimilation and appetite control, and is positioned as a non invasive alternative to pharmaceutical or injectable weight loss options. Promotional claims include rapid reduction in bloating and subjective weight loss in consumer trials; the release lacks detailed clinical data, regulatory approval statements, or safety study specifics.</description>
    <language>en-us</language>
    <pubDate>Thu, 12 Jun 2025 17:46:03 +0530</pubDate>
    <lastBuildDate>Thu, 12 Jun 2025 17:46:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=828670" rel="self" type="application/rss+xml"/>
    <item>
      <title>Cureveda Launches “Weight-Gut” — A New-Age, Natural Solution Tackling Bloating, Cravings, and Stubborn Fat Through Gut Health</title>
      <link>https://www.taxtmi.com/news?id=46424</link>
      <description>Cureveda markets Weight Gut as a plant based enzyme and botanical formulation that targets poor digestion to reduce bloating, curb cravings, and support fat metabolism. The product combines a patented multi enzyme complex with botanicals purported to improve digestion, nutrient assimilation and appetite control, and is positioned as a non invasive alternative to pharmaceutical or injectable weight loss options. Promotional claims include rapid reduction in bloating and subjective weight loss in consumer trials; the release lacks detailed clinical data, regulatory approval statements, or safety study specifics.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Thu, 12 Jun 2025 17:46:03 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=46424</guid>
    </item>
  </channel>
</rss>